Numerous human and murine monoclonal antibodies (mAbs) binding to the S1 or S2 regions of the S protein have been identified and were shown to confer neutralizing activities in vitro and protection in vivo against SARS-CoV infection [25], [26], [27], [28]. Here, PROS1 is linked to severe acute respiratory syndrome.